Objective: Although homograft conduits are frequently used to establish right ventricle-to-pulmonary artery continuity, the limited availability of small-size homografts is a significant constraint in pediatric cardiac surgery. We compared the performance of standard homograft conduits with that of surgically reduced bicuspid homograft conduits in patients undergoing repair of truncus arteriosus.

Methods: Forty infants undergoing complete repair of truncus arteriosus with either standard homografts (n = 26) or reduced-size bicuspid homografts (n = 14) were evaluated.

Results: The median downsized conduit diameter (13 mm) was similar to the standard homograft diameter (12 mm, P = .52). There were 6 early deaths and 5 late deaths, representing an overall 30-day mortality of 15% and a 5-year mortality of 25%. No deaths were directly related to homograft dysfunction. Four (29%) downsized conduits and 8 (31%) standard conduits required replacement at a median interval of 18.5 months and 42.4 months, respectively. Catheter-based interventions were required in 5 (36%) patients in the downsized group and in 3 (12%) patients in the standard group. There was no difference in freedom from surgical or catheter-based reintervention between the 2 groups (P = .42). Freedom from conduit failure (severe conduit stenosis, moderate or greater regurgitation) was 55.9% and 17.2% at 3 years in the downsized and standard groups, respectively.

Conclusion: The surgically downsized homograft is an excellent option when an appropriate-sized homograft is not available and might prevent morbidity associated with the use of an oversized conduit.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtcvs.2006.02.041DOI Listing

Publication Analysis

Top Keywords

homograft conduits
16
homograft
8
downsized homograft
8
ventricle-to-pulmonary artery
8
standard homograft
8
repair truncus
8
conduits
6
standard
6
downsized
5
evaluation downsized
4

Similar Publications

Objective: Infected femoral artery pseudoaneurysms (IFAPs) are threatening complications of voluntary drug injections in the groin. The purpose of this study is to report the results of open and endovascular repair of IFAPs in intravenous drug abusers.

Methods: The IN-FEMS (INfected Femoral artery psEudoaneurysMs in drug addictS) is a physician-initiated, multicenter and retrospective registry of patients treated for native IFAPs between 2010 and 2023 in 18 different Italian Vascular Surgery Departments.

View Article and Find Full Text PDF

Background: There is no consensus on the preferred conduit for right ventricular outflow tract (RVOT) reconstruction for congenital cardiac disease.

Case Summary: We present a case of a 21-year-old woman with history of tetralogy of Fallot presenting with recurrent graft thrombosis and pulmonary emboli in the setting of RVOT reconstruction with a 20-mm expanded polytetrafluoroethylene (ePTFE) valved conduit (GORE PV1, W.L.

View Article and Find Full Text PDF

This 27-year-old female patient is undergoing a reoperation for a recurrent subaortic membrane causing significant left ventricular outflow obstruction. The re-sternotomy is uneventful and cardiopulmonary bypass is established. The left ventricular outflow tract is accessed through the previously implanted semi-calcified homograft aortic root.

View Article and Find Full Text PDF

Conduit Size, Branch Pulmonary Artery Size, and Reoperation in Patients With Truncus Arteriosus.

World J Pediatr Congenit Heart Surg

February 2025

Division of Thoracic and Cardiovascular Surgery, Department of Surgery, Indiana University School of Medicine, Riley Hospital for Children at Indiana University Health, Indianapolis, IN, USA.

Background: Optimal right ventricle-to-pulmonary artery (RV-PA) conduit size for patients with truncus arteriosus is controversial. We aimed to determine the relationship between branch PA size and the need for conduit reoperation following repair of truncus arteriosus.

Methods: We performed a single-center chart review of patients who underwent truncus arteriosus repair from January 2009 to December 2023.

View Article and Find Full Text PDF

Background: The Melody TPV has been used as an alternative to surgical pulmonary valve replacement; limited medium-term follow-up data are available.

Aims: To report the follow-up data of all Melody TPVs implanted locally over a 15-year period (2006-2021).

Methods: Single-centre non-randomised prospective observational study of all implanted Melody valves in the pulmonary position.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!